Skip to main content
. Author manuscript; available in PMC: 2016 Apr 14.
Published in final edited form as: Am J Obstet Gynecol. 2014 Apr 23;211(5):512.e1–512.e6. doi: 10.1016/j.ajog.2014.04.027

TABLE 1.

Demographic characteristics of study population

Characteristic Diabetes
n = 233
Chronic HTN
n = 387
Multiple gestation
n = 315
Previous preeclampsia
n = 323
P valuea
Maternal age at
randomization, mean ± SD
26.0 (6.04) 29.5 (6.48) 25.0 (5.88) 24.4 (5.40) <.001
Race, n (%)
  White 139 (59.66) 96 (24.81) 109 (34.60) 71 (21.98) <.001
  Hispanic 15 (6.44) 36 (9.30) 37 (11.75) 8 (2.48)
  African American 77 (33.05) 254 (65.63) 168 (53.33) 244 (75.54)
  Other 2 (0.86) 1 (0.26) 1 (0.32) 0 (0.00)
Parity (deliveries >20 wks),
mean ± SD
0.82 (1.20) 1.62 (1.60) 1.11 (1.21) 1.77 (1.14) <.001
Body mass index (kg/m2),
geometric mean (95% CI)
27.1 (26.23–27.96) 31.9 (31.08–32.78) 25.7 (24.99–26.36) 27.4 (26.57–28.16) <.001
Gestational age at enrollment
(wks), mean ± SD
18.0 (3.69) 19.8 (3.79) 21.1 (3.60) 20.0 (3.96) <.001
Gestational age at delivery
(wks), mean ± SD
36.0 (4.10) 36.9 (3.97) 34.4 (3.59) 37.5 (3.63) <.001
Infant death, n (%) 1 (0.43) 3 (0.78) 9 (2.86) 3 (0.93) .06
Maternal death, n (%) 0 (0.00) 0 (0.00) 0 (0.00) 1 (0.17) .69

CI, confidence interval; HTN, hypertension.

a

Comparisons between groups were made using analysis of variance for continuous variables, χ2 tests for categorical measures, and Fisher exact test for infant and maternal death.

Metz. Preeclampsia biomarkers in high-risk groups. Am J Obstet Gynecol 2014.